Search

Your search keyword '"Institut de pharmacologie et de biologie structurale (IPBS)"' showing total 47 results

Search Constraints

Start Over You searched for: Author "Institut de pharmacologie et de biologie structurale (IPBS)" Remove constraint Author: "Institut de pharmacologie et de biologie structurale (IPBS)" Publication Year Range This year Remove constraint Publication Year Range: This year
47 results on '"Institut de pharmacologie et de biologie structurale (IPBS)"'

Search Results

1. Nucleotidyltransferase toxin MenT extends aminoacyl acceptor ends of serine tRNAs to control Mycobacterium tuberculosis growth.

2. In vitro evaluation of ganaplacide/lumefantrine combination against Plasmodium falciparum in a context of artemisinin resistance.

3. Ezrin, radixin, and moesin are dispensable for macrophage migration and cellular cortex mechanics.

4. Functional analysis of MS-based proteomics data: from protein groups to networks.

5. Trehalose polyphleates participate in Mycobacterium abscessus fitness and pathogenesis.

6. Coarse-Graining the Recognition of a Glycolipid by the C-Type Lectin Mincle Receptor.

7. Streamlined analysis of drug targets by proteome integral solubility alteration indicates organ-specific engagement.

8. Synthesis and biological evaluation of natural Lachnophyllum methyl ester, Lachnophyllum lactone and their synthetic analogs.

9. Digital One-Step Competitive Detection of a Small Molecule in Synthetic and Environmental Waters.

10. 6-Phosphogluconolactonase is critical for the efficient functioning of the pentose phosphate pathway.

11. SURF2 is a MDM2 antagonist in triggering the nucleolar stress response.

12. NMDA Receptors: Distribution, Role, and Insights into Neuropsychiatric Disorders.

13. In artemisinin-resistant falciparum malaria parasites, mitochondrial metabolic pathways are essential for survival but not those of apicoplast.

14. Surface-anchored carbon nanomaterials for antimicrobial surfaces.

15. Medicago truncatula SOBIR1 controls pathogen immunity and specificity in the Rhizobium-legume symbiosis.

16. Structural Optimization of Azacryptands for Targeting Three-Way DNA Junctions.

17. Integrative in vivo analysis of the ethanolamine utilization bacterial microcompartment in Escherichia coli .

18. Identification of potent indolizine derivatives against Mycobacterial tuberculosis: In vitro anti-TB properties, in silico target validation, molecular docking and dynamics studies.

19. ADP-ribosylome analysis reveals homogeneous DNA-damage-induced serine ADP-ribosylation across wild-type and BRCA-mutant breast cancer cell lines.

20. Characterization of antimalarial activity of artemisinin-based hybrid drugs.

22. Imputation of label-free quantitative mass spectrometry-based proteomics data using self-supervised deep learning.

23. Peptide-Alkoxyamine Drugs: An Innovative Approach to Fight Schistosomiasis: "Digging Their Graves with Their Forks".

24. TL1A is an epithelial alarmin that cooperates with IL-33 for initiation of allergic airway inflammation.

25. Fibroblasts transfection by electroporation in 3D reconstructed human dermal tissue.

26. Editorial: The early life window of opportunity: role of the microbiome on immune system imprinting.

27. A host-directed oxadiazole compound potentiates antituberculosis treatment via zinc poisoning in human macrophages and in a mouse model of infection.

28. Altered serine metabolism promotes drug tolerance in Mycobacterium abscessus via a WhiB7-mediated adaptive stress response.

29. Dual-action compounds unleash a one-two punch against tuberculosis.

30. Impact of Methylthioxylose Substituents on the Biological Activities of Lipomannan and Lipoarabinomannan in Mycobacterium tuberculosis .

31. Cytidine Deaminase Resolves Replicative Stress and Protects Pancreatic Cancer from DNA-Targeting Drugs.

32. HadBD dehydratase from Mycobacterium tuberculosis fatty acid synthase type II: A singular structure for a unique function.

33. The immunoglobulin heavy chain super enhancer controls class switch recombination in developing B cells.

34. Evolutionary analysis reveals the role of a non-catalytic domain of peptidyl arginine deiminase 2 in transcriptional regulation.

35. The C-type lectin DCIR contributes to the immune response and pathogenesis of colorectal cancer.

36. Hybrid Peptide-Alkoxyamine Drugs: A Strategy for the Development of a New Family of Antiplasmodial Drugs.

37. In silico design, synthesis and antitubercular activity of novel 2-acylhydrazono-5-arylmethylene-4-thiazolidinones as enoyl-acyl carrier protein reductase inhibitors.

38. RNA and the RNA-binding protein FUS act in concert to prevent TDP-43 spatial segregation.

39. Bacterial host adaptation through sequence and structural variations of a single type III effector gene.

40. Epigenetic regulation as a therapeutic target in the malaria parasite Plasmodium falciparum.

41. Kinetic solubility: Experimental and machine-learning modeling perspectives.

42. Visualizing the impact of disease-associated mutations on G protein-nucleotide interactions.

43. Exploring the plasticity of the InhA substrate-binding site using new diaryl ether inhibitors.

44. The chemokine receptor CCR5: multi-faceted hook for HIV-1.

45. WOMBAT-P: Benchmarking Label-Free Proteomics Data Analysis Workflows.

46. Cancer Imaging by Intravital Microscopy: The Dorsal Window Chamber Model.

47. Molecular Dynamics as a Tool for Virtual Ligand Screening.

Catalog

Books, media, physical & digital resources